According to Fortune Business Insights, the global bioresorbable coronary stents market size was valued at USD 356.03 million in 2025 and is projected to grow from USD 372.81 million in 2026 to USD 593.15 million by 2034, exhibiting a CAGR of 5.98% during the forecast period. North America dominated the global bioresorbable coronary stents market with a market share of 5.89% in 2025.
The market is witnessing steady growth due to the increasing prevalence of coronary artery diseases, rising demand for minimally invasive cardiovascular procedures, growing adoption of advanced interventional cardiology technologies, and continued development of next-generation bioresorbable scaffold materials.
Key Market Drivers
Increasing Prevalence of Coronary Artery Diseases
The rising burden of cardiovascular diseases and coronary artery disorders is increasing demand for advanced stent technologies and minimally invasive treatment procedures.
Growing Demand for Minimally Invasive Cardiac Procedures
Patients and healthcare providers are increasingly adopting minimally invasive interventional cardiology procedures that reduce recovery times and hospital stays.
Advancements in Bioresorbable Stent Technologies
Continuous developments in scaffold materials, drug-eluting technologies, device designs, and manufacturing processes are supporting market growth.
Market Restraints
High Cost of Advanced Bioresorbable Stents
The development and adoption of advanced bioresorbable coronary stents can involve significant manufacturing, clinical testing, and procedural costs.
Complex Regulatory Approval Requirements
Stringent clinical evaluation, safety standards, and regulatory approval processes can increase product development timelines and commercialization costs.
Get Sample PDF Here: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/bioresorbable-coronary-stents-market-113733
Market Opportunities
Development of Next-Generation Bioresorbable Scaffolds
Advancements in biodegradable polymers, metallic scaffolds, thinner struts, and improved drug-delivery technologies are creating opportunities for innovative coronary stent products.
Expansion of Cardiovascular Healthcare Infrastructure
Increasing investments in hospitals, specialty clinics, catheterization laboratories, and interventional cardiology services are creating growth opportunities for market participants.
Segmentation
By Application
- Acute Coronary Syndrome (ACS)
- Chronic Coronary Syndrome (CCS)
By End-user
- Hospitals & ASCs
- Specialty Clinics
- Others
Regional Insights
North America
North America dominated the bioresorbable coronary stents market with a share of 5.89% in 2025. The region benefits from advanced cardiovascular healthcare infrastructure, increasing adoption of minimally invasive cardiac procedures, and continued investments in innovative medical device technologies.
Europe
Europe remains a significant market supported by established cardiovascular healthcare systems, increasing adoption of advanced interventional cardiology procedures, and continued research and development activities.
Asia Pacific
Asia Pacific is expected to witness growth during the forecast period due to increasing prevalence of cardiovascular diseases, expanding healthcare infrastructure, rising healthcare expenditure, and growing adoption of advanced coronary intervention technologies.
Rest of the World
Latin America and the Middle East & Africa are gradually increasing adoption of advanced cardiovascular medical devices as healthcare infrastructure and access to interventional cardiology procedures continue to improve.
Get Sample PDF Here: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/bioresorbable-coronary-stents-market-113733
Key Players in the Bioresorbable Coronary Stents Market
- Abbott Laboratories
- Biotronik SE & Co. KG
- Elixir Medical Corporation
- REVA Medical, LLC
- Meril Life Sciences Pvt. Ltd.
- Arterial Remodeling Technologies S.A.
- Amaranth Medical, Inc.
- Kyoto Medical Planning Co., Ltd.
- Lepu Medical Technology (Beijing) Co., Ltd.
- MicroPort Scientific Corporation
Conclusion
The global bioresorbable coronary stents market is expected to witness steady growth through 2034, driven by the increasing prevalence of coronary artery diseases, rising demand for minimally invasive cardiovascular procedures, and advancements in bioresorbable scaffold technologies. Continued innovation in biodegradable materials, drug-eluting technologies, and next-generation coronary stent designs is expected to create significant growth opportunities for market participants during the forecast period.